Cefmast DC
| Species | Cattle (cows in the dry period) |
|---|---|
| Composition | Active substance: Cefquinome - 150 mg (equivalent to 178.57 mg cefquinome sulfate) |
| Indications | For cows in the dry period, intended for the treatment of subclinical mastitis and the prevention of newly occurring bacterial infections during this period, caused by microorganisms sensitive to cefquinome: Streptococcus uberis, Streptococcus dysgalactiae, Streptococcus agalactiae, Staphylococcus aureus, and coagulase-negative staphylococci. |
| Dosage and method of administration |
Single intramammary administration. 150 mg cefquinome, equivalent to one syringe, should be carefully introduced into each quarter immediately after the last milking. Before treatment, the udder must be completely milked out. The teat and its opening should be thoroughly cleaned and disinfected. Measures should be taken to avoid contamination of the injector nozzle. Carefully insert 5 mm of the total length of the nozzle and inject the contents of one syringe into each quarter. The product is dispersed by gently massaging the teat and udder. The syringe is for single use only. |
| Contraindications | Not to be used in animals known to be hypersensitive to cephalosporins or other beta-lactam antibiotics. Not to be administered to cows with clinical mastitis. |
| Waiting period | Meat and organs: 0 days. Milk: 12 hours after calving (after the standard dry period of 5-9 weeks). If the dry period was shorter than 6 weeks, it is recommended to test the milk for residues before delivery. |
| Release form |
Primary packaging: Low-density polyethylene syringe with a low-density polyethylene cap, containing 3 g of product. Secondary packaging: Cardboard box containing 24 syringes x 3 g of product. |
| Storage conditions | Store in a dark place, separate from food and feed, at T°C 5°C + 25°C, in places inaccessible to children. |
| Shelf life |
As indicated on the packaging. Do not use after the expiry date indicated on the packaging. |